Mohamad Abedi, an assistant professor of bioengineering, has received a 2026 Cytokine Society-Regeneron New Investigator Award for Excellence in Cytokine & Interferon Research.

Abedi leads a research group that aims to reverse-engineer the fundamental mechanisms of biological systems and rebuild them into new capabilities for human health and sustainability. This includes designing novel proteins and synthetic signaling systems to control immune cell communication. His work combines AI-driven protein design, synthetic biology and high-throughput experimentation to create new cytokines, receptors, and context-aware immunotherapies to treat cancer and immune disorders.

Before joining the UCLA Samueli School of Engineering faculty in July, Abedi completed postdoctoral training at the University of Washington Institute for Protein Design and earned his Ph.D. at Caltech.

His work has been recognized by the Paul & Daisy Soros Fellowship, NSF Graduate Research Fellowship, HHMI Jane Coffin Childs Fellowship and the Michelson Prize: Next Generation Grants.

Abedi was one of eight new investigator awardees. They were recognized at the meeting, held Oct. 18-21 in Glasgow, U.K.